Human Cloning Isn’t Monkey Business
By Osagie K. Obasogie,
Genetic Crossroads
| 11. 29. 2007
Rarely have science, politics, and international diplomacy converged as intensely as they have over the past few days.
Researchers at the Oregon National Primate Research Center have accomplished what some scientists equate with breaking the sound barrier: creating cloned embryos from an adult monkey and isolating its stem cells. Since monkeys are humans' closest relatives and embryonic stem cells might treat devastating injuries and diseases, this research has invigorated prospects for developing patient-specific embryonic stem cells for humans by copying the Oregon researchers' new approach. After all, monkey see, monkey do.
Yet another level of intrigue comes from the fact that cloning an embryo to obtain stem cells involves the same underlying process as cloning an embryo to create a living, breathing clone: taking the nucleus from a body cell, sticking it into an egg, and triggering its early development. Research cloning involves stopping this development after a few days to cull the early embryos' stem cells; reproductive cloning entails placing the developing embryo into a surrogate until the clone is born.
Scientists have not yet created a living cloned...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...